Top Markets
Coin of the day
Citius Oncology, Inc. Citius Oncology, Inc.

Citius Oncology, Inc.

CTOR
Rangering i aksjer #23802
Citius Oncology, Inc. concentrates on advancing innovative, targeted... Citius Oncology, Inc. concentrates on advancing innovative, targeted therapeutic solutions for various cancer types. A key aspect of its pipeline includes the development of LYMPHIR, an investigational orphan drug intended to treat adults battling cutaneous T-cell lymphoma that has either relapsed or is unresponsive to existing therapies. The firm's main offices are situated in New York, New York. Citius Oncology, Inc. functions as a division of its parent company, Citius Pharmaceuticals, Inc.
Aksjekurs
$0.7426
Sist synkronisert: 2026-08-21
Markedsverdi
$69.05M
Endring (1 dag)
-2.17%
Endring (1 år)
-57.57%
Land
US
Handel Citius Oncology, Inc. (CTOR)

Kategori

Historikk for aksjesplitt for Citius Oncology, Inc. (CTOR)
Aksjen Citius Oncology, Inc. (symbol: CTOR) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 22, 2026.
Én CTOR-aksje kjøpt før Aug 22, 2026 tilsvarer i dag 0 CTOR-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
4 x15
US
7 x432
US
0 -
US
2 x10000
CH
7 x226
US